Learn the rules, benefits, and limits of Trump Savings Accounts—a new OBBBA-created, tax-deferred savings option for children ...

Lan Anh Tran: The search for well-constructed high dividend yield ETFs can be fraught with difficult choices. The classic ...

WINNIPEG, Manitoba--Canola futures on the Intercontinental Exchange were slightly higher Wednesday as comparable oils were mixed. European rapeseed was up, but Chicago soyoil and Malaysian palm oil ...

Shares of Target Corp. tumbled in early trading Wednesday, after the discount retailer said it was replacing Chief Executive Brian Cornell, who has been in charge for the past 11 years, with current ...

"Tariffs are starting to show up a bit in price," he said, noting that Home Depot posted a 1.4% increase in comparable average ticket growth - a gauge of average price paid per transaction - during ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...

Eli Lilly's top neuroscience executive, Anne White, is retiring after three decades with the drugmaker. Eli Lilly on Wednesday said White will remain in her post as executive vice president and ...

The company, which is the parent of TJ Maxx, Marshalls, HomeGoods, Homesense and Sierra store brands in the U.S., also beat fiscal second-quarter earnings expectations and raised its full-year outlook ...

My friend is working on an exit plan' "I did recommend not making any sudden moves, because it could look like they are trying to hide assets." (Photo subject is a model.) Dear Quentin, Are assets - ...

Stock market will have to navigate a 'bifurcated economy' Meredith Whitney, pictured in 2023, says a 'bifurcated' U.S. economy spells trouble. Nearly two decades ago, financial analyst Meredith ...

On a per-share basis, Lowe's lowered its full-year earnings guidance to between $12.10 and $12.35 from the prior range of $12.15 to $12.40. It expects adjusted earnings of $12.20 to $12.45 a share.

HLS Therapeutics agreed a new Canadian dollar-denominated credit deal aimed at boosting its financial flexibility and reducing foreign-exchange exposure and lowering the interest rate.